Navigation Links
John Timberlake, Valeritas' Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
Date:10/23/2007

PARSIPPANY, N.J., Oct. 23 /PRNewswire/ -- Valeritas, LLC, a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that John Timberlake, Executive Vice President and General Manager of Valeritas, LLC was awarded the distinguished Executive of Year award by the Diabetes Foundation, an organization dedicated to the needs of patients with diabetes in New Jersey.

"John's continued commitment to improving the quality of care for patients with diabetes made him an obvious choice for Executive of the Year," said Sam Fusco, Chairman of the Board of the Diabetes Foundation. "We are honored to have John among this elite group of executives, and look forward to working with him to improve the lives of people suffering with diabetes in New Jersey."

Mr. Timberlake has devoted nearly half of his 21-year career to the commercialization of new treatments for patients with diabetes. In his current role at Valeritas, he is focused on commercializing and launching the lead product in the Valeritas portfolio -- the h-Patch(TM) disposable insulin delivery device, a once-daily, simple-to-use, discreet insulin delivery device that provides both a continuous set basal rate of insulin and on-demand bolus dosing for mealtime coverage. The h-Patch(TM) is expected to be available in the New Jersey area in the first half of 2008 and nationally by the end of 2008.

"I am very honored to accept this award from an organization dedicated to the fight against diabetes," said Mr. Timberlake. "While there have been great strides in improving treatment options for people with diabetes and there is less stigma about taking insulin, more needs to be done. At Valeritas, the h-Patch(TM) technology has been designed to provide patients with a drug delivery option that mimics the physiologic distribution of insulin in a simple fashion which will improve compliance and ultimately lead to better control. I am
'/>"/>

SOURCE Valeritas, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Chemical-petroleum executive joins Virent Energy board
2. Visions: Matheys says CIO role is good training for executive suite
3. Biotech executive books a career flight thats closer to home
4. CEOs Gone Wild? Risks and rewards in the executive suite
5. Early-stage executives hear from investors
6. Pedlar the latest executive to leave Merge
7. Financial executives to launch Madison chapter
8. Former Thompson lawyer comments on Doyle stem cell executive order
9. Republican sees nothing wrong with Doyles use of executive order
10. Executives hear about promise, limits of RFID and nanotech
11. RoleFlow launches process-management software for executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... MORRISTOWN, N.J. , July 28, 2015 /PRNewswire/ ... its second Phase 1 clinical trial with MMI-0100, ... that is being developed for pulmonary disorders characterized ... the United Kingdom , is ... study further evaluating the safety and tolerability of ...
(Date:7/28/2015)... , July 28, 2015 CSL Behring ... Administration has accepted for review the company,s Biologics License ... single-chain (rVIII-SingleChain) for the treatment of hemophilia A. In ... Hemophilia A is a ... VIII; nearly all affected patients are male. People with ...
(Date:7/28/2015)... Md. and RESEARCH TRIANGLE PARK, N.C., July 28, 2015 ... today announced its financial results for the second ...  sales grew nearly 300% as compared to the ... first launched," said Roger Jeffs, Ph.D., United Therapeutics, ... Orenitram sales was due to an increase in ...
(Date:7/28/2015)... 2015  Faced with increasing challenges such as ... than symptomatic, the global healthcare industry today is ... of curing or significantly changing the course of ... towards regenerative medicine as a viable alternative. ... human health with the potential to resolve unmet ...
Breaking Biology Technology:Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5
... only one-tenth the size of a human hair, but ... the intense heat and radiation of next generation nuclear ... power-generating reactors are being designed to provide low-cost electricity, ... not have. , The Department of Energy (DoE) ...
... Research &,Instrumentation, Inc. (CRi) announces the launch of ... brightfield or,fluorescent microscope into a multispectral imaging workstation. ... as embryos,zebrafish, plants, tissue culture and microtiter plates, ... macroscope. The Nuance 2 system will be,showcased at ...
... Inc. (OTC,Bulletin Board: SCIE) announced today that Jim Dorst ... and Chief Financial Officer., Jim Hitchin the Company,s ... of,experience in public medical device, manufacturing and software firms. ... ago. With a graduate,degree in accounting, he is well ...
Cached Biology Technology:Clemson researcher studies carbon fibers for nuclear reactor safety 2CRi Announces Nuance 2, the Next-Generation Multispectral Imaging System for Brightfield and Fluorescent-Based Microscopy 2Jim Dorst Joins SpectraScience as CFO 2
(Date:6/25/2015)... 25, 2015 According to ... (Swipe & Area), Technology, Material (Optical Prism, Piezoelectric, ... Security & Others) & Geography - Global Forecast ... said market is expected to reach $14,500.07 Million ... Browse 76 market Tables and 109 ...
(Date:6/24/2015)... 2015 This report provides market analysis of ... years. It contains an analysis of the drivers, challenges, ... impact from the short, medium, and long term perspective ... market, and technology trends that currently, prevail in the ... authorities to efficiently manage the increasing marine traffic and ...
(Date:6/23/2015)... 23, 2015   MedNet Solutions , an ... entire spectrum of clinical research, is pleased to ... , the company,s intuitive, flexible and affordable cloud-based ... 2015 Stevie® Award by the American Business ... Website category.  The American Business Awards are considered ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... evolution works by reversing the process, reconstructing a 530-million-year-old ... genes that descended from the archaic gene. , "It ... evolution has occurred and is occurring, and thus makes ... and co-chairman of human genetics at the University of ...
... important new paper forthcoming in the June issue of ... University) argues against the widely held theory that the ... a large, replicating molecule such as RNA. Instead, ... a "stupendously improbable accident," presenting the more plausible idea ...
... of Warwick has found that sleep deprivation is associated ... obese for both children and adults. , Early results ... University of Warwick's Warwick Medical School were presented to ... the University of Warwick. , The research reviewed current ...
Cached Biology News:Scientists reverse evolution 2Scientists reverse evolution 3Scientists reverse evolution 4Scientists reverse evolution 5Sleep deprivation doubles risks of obesity in both children and adults 2
... Detergent Clean-up Micro Kit provides a fast and ... Triton X-100 and other detergents from small samples ... Norgens patented protein resin as an ion exchanger. ... g of either acidic or basic protein.A complete ...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates....
... cells form from a hematopoietic stem cells ... to the bone surface and lowering the ... around 4.5. The bone mineral is then ... and function is controlled primarily by Macrophage ...
Values of steady state parameters for enzyme activities are determined....
Biology Products: